These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28839818)

  • 1. Burden of irritable bowel syndrome in an increasingly cost-aware National Health Service.
    Soubieres A; Wilson P; Poullis A; Wilkins J; Rance M
    Frontline Gastroenterol; 2015 Oct; 6(4):246-251. PubMed ID: 28839818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
    Mearin F; Caballero AM; Serra J; Brotons C; Tantiñà A; Fort E; Martínez-Cerezo FJ; Perelló A; Sánchez-Antolín G; Rey E; Angós Musgo R; Berdier R; Gómez-Rodríguez B; Clavé P; García-Alonso M; Torán-Monserrat P; Tack J
    Gastroenterol Hepatol; 2019 Mar; 42(3):141-149. PubMed ID: 30612850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the burden of irritable bowel syndrome: analysis of a nationwide korean database.
    Jung HK; Kim YH; Park JY; Jang BH; Park SY; Nam MH; Choi MG
    J Neurogastroenterol Motil; 2014 Apr; 20(2):242-52. PubMed ID: 24840377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM; Chalder T; McCrone P; Darnley S; Knapp M; Jones RH; Wessely S
    Health Technol Assess; 2006 Jun; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting.
    Akehurst RL; Brazier JE; Mathers N; O'Keefe C; Kaltenthaler E; Morgan A; Platts M; Walters SJ
    Pharmacoeconomics; 2002; 20(7):455-62. PubMed ID: 12093301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.
    Everitt HA; Landau S; O'Reilly G; Sibelli A; Hughes S; Windgassen S; Holland R; Little P; McCrone P; Bishop FL; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):863-872. PubMed ID: 31492643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of irritable bowel syndrome in China.
    Zhang F; Xiang W; Li CY; Li SC
    World J Gastroenterol; 2016 Dec; 22(47):10450-10460. PubMed ID: 28058026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality.
    Shivaji UN; Ford AC
    Prim Health Care Res Dev; 2015 May; 16(3):263-9. PubMed ID: 25287958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population.
    Guerin A; Carson RT; Lewis B; Yin D; Kaminsky M; Wu E
    J Med Econ; 2014 Aug; 17(8):577-86. PubMed ID: 24811855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland.
    Fisher M; Walker A; Falqués M; Moya M; Rance M; Taylor D; Lindner L
    Eur J Health Econ; 2016 Dec; 17(9):1091-1100. PubMed ID: 26728984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of irritable bowel syndrome: A clinical review.
    Gilkin RJ
    Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan.
    Lai YT; Chen CY; Bair MJ
    Front Pharmacol; 2021; 12():788795. PubMed ID: 34975485
    [No Abstract]   [Full Text] [Related]  

  • 14. Using best practice to create a pathway to improve management of irritable bowel syndrome: aiming for timely diagnosis, effective treatment and equitable care.
    Williams M; Barclay Y; Benneyworth R; Gore S; Hamilton Z; Matull R; Phillips I; Seamark L; Staveley K; Thole S; Greig E
    Frontline Gastroenterol; 2016 Oct; 7(4):323-330. PubMed ID: 27761233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
    Buono JL; Carson RT; Flores NM
    Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of irritable bowel syndrome in the UK and US.
    Maxion-Bergemann S; Thielecke F; Abel F; Bergemann R
    Pharmacoeconomics; 2006; 24(1):21-37. PubMed ID: 16445300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.
    Tack J; Stanghellini V; Mearin F; Yiannakou Y; Layer P; Coffin B; Simren M; Mackinnon J; Wiseman G; Marciniak A;
    BMC Gastroenterol; 2019 May; 19(1):69. PubMed ID: 31064345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Societal costs for irritable bowel syndrome--a population based study.
    Hillilä MT; Färkkilä NJ; Färkkilä MA
    Scand J Gastroenterol; 2010 May; 45(5):582-91. PubMed ID: 20166844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of irritable bowel syndrome: a community survey.
    Wilson S; Roberts L; Roalfe A; Bridge P; Singh S
    Br J Gen Pract; 2004 Jul; 54(504):495-502. PubMed ID: 15239910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.